<?xml version="1.0" encoding="UTF-8"?>
<p>The primary endpoint of the study, as in the TRICOLORE trial, was the PFS, which was defined as the period from the date of enrollment to the date of either tumor progression or death due to any reason. The OS was defined as the period from the date of enrollment to the date of death.</p>
